• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Plasticity in growth behavior of patients' acute myeloid leukemia stem cells growing in mice.

作者信息

Ebinger Sarah, Zeller Christina, Carlet Michela, Senft Daniela, Bagnoli Johannes W, Liu Wen-Hsin, Rothenberg-Thurley Maja, Enard Wolfgang, Metzeler Klaus H, Herold Tobias, Spiekermann Karsten, Vick Binje, Jeremias Irmela

机构信息

Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, Germany.

Anthropology and Human Genomics, Dept. of Biology II, Ludwig-Maximilians-University, Martinsried.

出版信息

Haematologica. 2020 Dec 1;105(12):2855-2860. doi: 10.3324/haematol.2019.226282.

DOI:10.3324/haematol.2019.226282
PMID:33256387
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7716350/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d1/7716350/a57364a764ee/1052855.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d1/7716350/32c7ad753eb2/1052855.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d1/7716350/ab7d304a715e/1052855.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d1/7716350/a57364a764ee/1052855.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d1/7716350/32c7ad753eb2/1052855.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d1/7716350/ab7d304a715e/1052855.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d1/7716350/a57364a764ee/1052855.fig3.jpg

相似文献

1
Plasticity in growth behavior of patients' acute myeloid leukemia stem cells growing in mice.患者急性髓系白血病干细胞在小鼠体内生长时生长行为的可塑性。
Haematologica. 2020 Dec 1;105(12):2855-2860. doi: 10.3324/haematol.2019.226282.
2
RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia.RHAMM/HMMR（CD168）不是急性髓细胞白血病免疫治疗的理想靶抗原。
Haematologica. 2012 Oct;97(10):1539-47. doi: 10.3324/haematol.2012.065581. Epub 2012 Apr 24.
3
Identification of a subset of patients with acute myeloid leukemia characterized by long-term in vitro proliferation and altered cell cycle regulation of the leukemic cells.鉴定出一组具有急性髓系白血病特征的患者，这些患者的白血病细胞具有长期体外增殖和改变的细胞周期调控。
Expert Opin Ther Targets. 2014 Nov;18(11):1237-51. doi: 10.1517/14728222.2014.957671. Epub 2014 Sep 9.
4
MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.微小RNA-9通过下调Hes1促进核型正常的成人CD34阳性急性髓细胞白血病中白血病细胞的增殖。
Tumour Biol. 2016 Jun;37(6):7461-71. doi: 10.1007/s13277-015-4581-x. Epub 2015 Dec 17.
5
Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia.蛋白激酶 CK2 调节 AKT、NF-κB 和 STAT3 的激活、急性髓系白血病干细胞的存活和增殖。
Leukemia. 2017 Feb;31(2):292-300. doi: 10.1038/leu.2016.209. Epub 2016 Aug 1.
6
MicroRNA-34a-mediated death of acute myeloid leukemia stem cells through apoptosis induction and exosome shedding inhibition via histone deacetylase 2 targeting.miRNA-34a 通过靶向组蛋白去乙酰化酶 2 抑制细胞凋亡诱导和外泌体释放来杀死急性髓系白血病干细胞。
IUBMB Life. 2020 Jul;72(7):1481-1490. doi: 10.1002/iub.2273. Epub 2020 Mar 17.
7
Ginsenoside Rg1 Inhibits Cell Proliferation and Induces Markers of Cell Senescence in CD34+CD38- Leukemia Stem Cells Derived from KG1α Acute Myeloid Leukemia Cells by Activating the Sirtuin 1 (SIRT1)/Tuberous Sclerosis Complex 2 (TSC2) Signaling Pathway.人参皂苷 Rg1 通过激活沉默调节蛋白 1（SIRT1）/结节性硬化复合物 2（TSC2）信号通路抑制来源于 KG1α 急性髓系白血病细胞的 CD34+CD38- 白血病干细胞的增殖并诱导其衰老标志物的表达。
Med Sci Monit. 2020 Feb 10;26:e918207. doi: 10.12659/MSM.918207.
8
Inhibited CD47 gene affects the clearance of acute myelogenous leukemia stem cells.抑制 CD47 基因影响急性髓系白血病干细胞的清除。
J Cell Biochem. 2019 Jun;120(6):10303-10309. doi: 10.1002/jcb.28314. Epub 2018 Dec 19.
9
Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion.miR-99a的上调与急性髓系白血病的不良预后相关，并促进髓系白血病细胞的扩增。
Oncotarget. 2016 Nov 22;7(47):78095-78109. doi: 10.18632/oncotarget.12947.
10
Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.西达本胺与化疗药物的协同作用通过急性髓系白血病干祖细胞中DNA损伤积累和修复缺陷诱导细胞凋亡。
Clin Epigenetics. 2017 Aug 14;9:83. doi: 10.1186/s13148-017-0377-8. eCollection 2017.

引用本文的文献

1
Perturbing LSD1 and WNT rewires transcription to synergistically induce AML differentiation.干扰赖氨酸特异性去甲基化酶1（LSD1）和Wnt信号通路可重新连接转录，协同诱导急性髓系白血病（AML）分化。
Nature. 2025 Apr 16. doi: 10.1038/s41586-025-08915-1.
2
Epigenetic mechanisms controlling human leukemia stem cells and therapy resistance.控制人类白血病干细胞及治疗抗性的表观遗传机制。
Nat Commun. 2025 Apr 3;16(1):3196. doi: 10.1038/s41467-025-58370-9.
3
Effective eradication of acute myeloid leukemia stem cells with FLT3-directed antibody-drug conjugates.
使用FLT3导向抗体-药物偶联物有效根除急性髓性白血病干细胞。
Leukemia. 2025 Mar;39(3):632-642. doi: 10.1038/s41375-024-02510-5. Epub 2025 Jan 27.
4
Acute Myeloid Leukaemia and Acute Lymphoblastic Leukaemia Classification and Metabolic Characteristics for Informing and Advancing Treatment.急性髓系白血病和急性淋巴细胞白血病的分类及代谢特征，为治疗提供信息并推动治疗进展
Cancers (Basel). 2024 Dec 11;16(24):4136. doi: 10.3390/cancers16244136.
5
Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo.联合蛋白质组学和 CRISPR‒Cas9 筛选在 PDX 模型中鉴定出 ADAM10 对体内白血病的发生是必需的。
Mol Cancer. 2023 Jul 8;22(1):107. doi: 10.1186/s12943-023-01803-0.
6
X-linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL.X 连锁凋亡抑制蛋白是治疗复发/难治性 ALL 的一个很有前途的治疗靶点。
EMBO Mol Med. 2023 Jan 11;15(1):e14557. doi: 10.15252/emmm.202114557. Epub 2022 Nov 23.
7
A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid Leukemia.动态 rRNA 核糖甲基组驱动急性髓系白血病的干性。
Cancer Discov. 2023 Feb 6;13(2):332-347. doi: 10.1158/2159-8290.CD-22-0210.
8
Generation and proof-of-concept for allogeneic CD123 CAR-Delta One T (DOT) cells in acute myeloid leukemia.异体 CD123 CAR-Delta One T（DOT）细胞在急性髓细胞白血病中的生成和概念验证。
J Immunother Cancer. 2022 Sep;10(9). doi: 10.1136/jitc-2022-005400.
9
Prime-seq, efficient and powerful bulk RNA sequencing.Prime-seq，高效且强大的批量 RNA 测序技术。
Genome Biol. 2022 Mar 31;23(1):88. doi: 10.1186/s13059-022-02660-8.
10
In vivo inducible reverse genetics in patients' tumors to identify individual therapeutic targets.在患者肿瘤中进行体内诱导性反向遗传学研究，以鉴定个体治疗靶点。
Nat Commun. 2021 Sep 27;12(1):5655. doi: 10.1038/s41467-021-25963-z.